Extracorporeal Shockwave Therapy Versus Placebo for the Treatment of Chronic Proximal Plantar Fasciitis: Results of a Randomized, Placebo-Controlled, Double-Blinded, Multicenter Intervention Trial

Malay, D. Scot; Pressman, Martin M.; Assili, Amir; Kline, Jason T.; York, Shane; Buren, Ben; Heyman, Eugene R.; Borowsky, Pam; LeMay, Carley

doi:10.1053/j.jfas.2006.04.007

Cited by 101 publications

(95 citation statements)

References 41 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Extracorporeal shock wave therapy (ESWT) has been proposed as a potential method of treating patients with chronic disease without the need to stop weightbearing [10,16,21,22].…”

Section: Introductionmentioning

confidence: 99%

Extracorporeal Shock Wave Therapy Is Effective In Treating Chronic Plantar Fasciitis: A Meta-analysis of RCTs

Aqil

Siddiqui

Solan

et al. 2013

Clinical Orthopaedics &Amp; Related Research

110

View full text Add to dashboard Cite

Background Plantar fasciitis is the most common cause of heel pain. It may remain symptomatic despite conservative treatment with orthoses and analgesia. There is conflicting evidence concerning the role of extracorporeal shock wave therapy (ESWT) in the management of this condition. Questions/purposes We investigated whether there was a significant difference in the change of (1) VAS scores and (2) Roles and Maudsley scores from baseline when treated with ESWT and placebo. Specifically we compared overall improvement from baseline composite VAS, reduction in overall VAS pain, success rate of improving overall VAS pain by 60%, success rate of improving VAS pain by 60% when taking first steps, doing daily activities, and during application of a pain pressure meter.Methods MEDLINE, Embase, and CINAHL databases were searched from January 1980 to January 2013 and a double extraction technique was used to obtain relevant studies. Studies had to be prospective randomized controlled trials on adults and must not have used local anesthesia as part of their treatment protocol. Studies must have specifically recruited patients who continued to be symptomatic despite a minimum of 3 months of conservative treatments. All papers were assessed regarding their methodologic quality and a meta-analysis performed. Seven prospective randomized controlled trials were included in this study. There were 369 patients included in the placebo group and 294 in the ESWT group. Results After ESWT, patients had better composite VAS scores (random effects model, standardized mean difference [SMD] = 0.38; 95% CI, 0.05, 0.72; z = 2.27). They also had a greater reduction in their absolute VAS scores compared with placebo (random effects model, SMD = 0.60; 95% CI, 0.34, 0.85; z = 4.64). Greater success of improving heel pain by 60% was observed after ESWT when taking first steps (random effects model, risk ratio [RR] = 1.30; 95% CI, 1.04, 1.62; z = 2.29) and during daily activities (random effects model, RR = 1.44; 95% CI, 1.13, 1.84; z = 2.96). Subjective measurement of pain using a pressure meter similarly favored ESWT (random effects model, RR = 1.37, 95% CI, 1.06, 1.78; z = 2.41). There was a significant difference in the change to

show abstract

“…Extracorporeal shock wave therapy (ESWT) has been proposed as a potential method of treating patients with chronic disease without the need to stop weightbearing [10,16,21,22].…”

Section: Introductionmentioning

confidence: 99%

Extracorporeal Shock Wave Therapy Is Effective In Treating Chronic Plantar Fasciitis: A Meta-analysis of RCTs

Aqil

Siddiqui

Solan

et al. 2013

Clinical Orthopaedics &Amp; Related Research

110

View full text Add to dashboard Cite

show abstract

“…Many placebo-controlled clinical studies have been published reporting that ESWT is a successful treatment in the treatment of plantar fasciitis with success rates reaching 94% [5,[10][11][12][13][14][15][16][17]19,20]. However, some researchers have reported that ESWT showed no difference in effect from a placebo in the treatment of plantar fasciitis [6,[21][22][23].…”

Section: Discussionmentioning

confidence: 99%

“…There have been many studies evaluating the efficacy of ESWT in the treatment of plantar fasciitis and although the majority of these studies have reported effective and successful results [5,7,[9][10][11][12][13][14][15][16][17][18][19][20], some researchers have stated that ESWT has had no effect [6,[21][22][23].…”

Section: Introductionmentioning

confidence: 99%

An Evaluation of the Efficacy of ESWT and Placebo-ESWT Treatment for Chronic Plantar Fasciitis

Aykol¹,

Ersoy²

2016

Med-Science

View full text Add to dashboard Cite

show abstract

“…The benefit of shock wave therapy for nonunions has already been reported in various experimental [2][3][4]10] and clinical studies [1,12,13,17]. More recently, shock wave has been introduced as therapy for other orthopaedic pathologies such as tendinopathies and bone necrosis [8,9,16,18]. This study reviews the results of 69 nonunions of long bone fractures treated with shock wave.…”

Section: Introductionmentioning

confidence: 89%

Extracorporeal shock wave treatment in nonunions of long bone fractures

Zhang

Jiang

Chen

et al. 2008

International Orthopaedics (SICOT)

View full text Add to dashboard Cite

We reviewed the clinical results of the past 7 years in order to investigate the effect of extracorporeal shock wave therapy (ESWT) in nonunions of long bone fracture. Sixty-nine patients with 69 nonunions (22 femora, 28 tibiae, 13 humeri, 5 radii, and 1 ulna) were treated with extracorporeal shock waves. The technical parameters were 6,000 to 10,000 impulses at 28 kV (0.62 mJ/mm 2 energy flux density) for the femur and tibia, 4,000 impulses at 24 kV for the humerus (0.56 mJ/mm 2 energy flux density), and 3,000 impulses at 24 kV (0.56 mJ/mm 2 energy flux density) for the radius and ulna. Sixty-six patients were followed up. The total successful rate of bony union was 75.4%. ESWT was successful in hypertrophic nonunions and seemed to have no evident effect in atrophic nonunions. We believe that extracorporeal shock wave therapy may be a good choice for nonunions of long bone fracture especially in hypertrophic nonunions.Résumé L'objectif de cette étude a été d'évaluer cliniquement les résultats observés sur les 7 dernières années lde a technique extracorporelle "schock wave" (ESWT) sur le traitement des pseudarthroses des os longs. Matériel et méthode : 69 patients présentant 69 pseudarthroses (22 fémurs, 28 tibias, 13 humérus, 5 radius et 1 cubitus) ont été traités selon cette méthode. Les paramètres techniques étaient de 6000 et de 10000 impulsions à 28 kV (062 mJ/mm2) pour le fémur et le tibia, 4000 impulsions à 24 kV pour l'humérus (0.56 mJ/mm2), 3000 impulsions à 24 kV (0.56 mJ/mm2) pour le radius et le cubitus. Résultats : 66 patients ont été suivis pendant au moins 12 mois. Le taux de consolidation a été de 75,4%. La ESWT est une technique qui permet de traiter une pseudarthrose hypertrophique alors qu'elle a peu d'effet sur les pseudarthroses atrophique. Conclusion : nous pensons que cette technique est une technique de choix pour les pseudarthroses des os longs spécialement lorsque ces pseudarthroses sont hypertrophiques.

show abstract

Extracorporeal Shockwave Therapy Versus Placebo for the Treatment of Chronic Proximal Plantar Fasciitis: Results of a Randomized, Placebo-Controlled, Double-Blinded, Multicenter Intervention Trial

Cited by 101 publications

References 41 publications

Extracorporeal Shock Wave Therapy Is Effective In Treating Chronic Plantar Fasciitis: A Meta-analysis of RCTs

Extracorporeal Shock Wave Therapy Is Effective In Treating Chronic Plantar Fasciitis: A Meta-analysis of RCTs

An Evaluation of the Efficacy of ESWT and Placebo-ESWT Treatment for Chronic Plantar Fasciitis

Extracorporeal shock wave treatment in nonunions of long bone fractures

Contact Info

Product

Resources

About